STAAR Surgical to Report Fourth Quarter Results on February 21, 2019
February 07 2019 - 7:00AM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of implantable lenses and companion
delivery systems for the eye, today announced that it will release
financial results for the fourth quarter and fiscal year ended
December 28, 2018 on Thursday, February 21, 2019 after the
market close.
STAAR will host a conference call and webcast on Thursday,
February 21 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to
discuss its financial results and operational progress. To access
the conference call (Conference ID 2888737), please dial
855-765-5684 for domestic participants and 262-912-6252 for
international participants. The live webcast can be accessed from
the investor relations section of the STAAR website at
www.staar.com.
A taped replay of the conference call (Conference ID 2888737)
will be available beginning approximately one hour after the call’s
conclusion for seven days. This replay can be accessed by dialing
855-859-2056 for domestic callers and 404-537-3406 for
international callers. An archived webcast will also be available
at www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 30 years, designs, develops, manufactures and markets
implantable lenses for the eye with companion delivery systems.
These lenses are intended to provide visual freedom for patients,
lessening or eliminating the reliance on glasses or contact lenses.
All of these lenses are foldable, which permits the surgeon to
insert them through a small incision. STAAR’s lens used in
refractive surgery is called an Implantable Collamer® Lens or
“ICL”, which includes the EVO Visian ICL™ product line. More than
900,000 Visian ICLs have been implanted to date. To learn more
about the ICL go to: www.discovericl.com. STAAR has
approximately 400 full-time equivalent employees and markets lenses
in over 75 countries. Headquartered in Monrovia, CA, the
company operates manufacturing facilities in Aliso Viejo,
CA and Monrovia, CA. For more information, please
visit the Company’s website at www.staar.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190207005004/en/
Investors & MediaEVC GroupBrian Moore,
310-579-6199Doug Sherk, 415-652-9100
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Mar 2024 to Apr 2024
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Apr 2023 to Apr 2024